Abstract
The screening for the management of diabetes mellitus must be included into regular HIV clinical care and clinicians must consider the metabolic effects of combinatorial drug therapy for HIV infection and its outcome. Studies are desirable to conclude the pathophysiologic explanation for the high prevalence of diabetes among HIVinfected who are on ART, and cohort studies with significant sample size are required to support.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
